QS BATTERYMARCH FINANCIAL MANAGEMENT, INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 110 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$1,258,000
-64.4%
121,103
-44.6%
0.03%
-63.3%
Q2 2014$3,537,000
-9.5%
218,570
-9.1%
0.09%
+12.5%
Q1 2014$3,907,000
+31.0%
240,3700.0%0.08%
+27.0%
Q4 2013$2,983,000
+12.4%
240,370
-0.8%
0.06%
+8.6%
Q3 2013$2,654,000242,3700.06%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders